Recombinant Enterobacteria phage PRD1 Protein P18 (XVIII) is a structural protein encoded by gene XVIII in bacteriophage PRD1, a member of the Tectiviridae family. It is critical for phage infectivity and DNA entry into host bacteria. The recombinant form is produced in Escherichia coli with an N-terminal His tag for purification and functional studies .
| Attribute | Detail |
|---|---|
| Gene | XVIII (synonyms: M, GpM) |
| UniProt ID | P27389 |
| Molecular Weight | ~12.6–12.8 kDa (estimated from amino acid sequence) |
| Host | Escherichia coli (recombinant expression) |
| Tag | His tag (N-terminal) |
| Protein Length | Full-length (1–90 amino acids) |
P18 is essential for PRD1’s infection cycle, particularly in DNA entry and virion stability:
P18 forms part of the tail-like structure that protrudes from the phage membrane during DNA ejection .
It works with proteins P11, P16, and P19 to facilitate ssDNA binding and translocation into the host cytoplasm .
Key Finding: P18-deficient phages fail to form the tubular tail structure, leading to spontaneous DNA release and loss of infectivity .
P18 is required for receptor recognition and membrane penetration. Mutations in XVIII result in non-infectious virions .
Contrast with P15: Unlike the lytic enzyme P15 (a soluble muramidase), P18 does not degrade the host cell wall but ensures proper membrane interaction during DNA packaging .
Recombinant P18 is produced for structural and functional studies:
Structural Studies: Used to analyze membrane-protein interactions in PRD1 assembly .
Functional Assays: Tested for binding to host receptors (e.g., IncP plasmid-encoded conjugation systems) .
Therapeutic Potential: Investigated for phage therapy targeting plasmid-carrying pathogens .
P18 stabilizes the phage capsid by preventing premature DNA ejection. P2-deficient mutants lacking P18 spontaneously release DNA, forming tail-like structures .
Mechanism: P18 interacts with the viral membrane to maintain capsid integrity until receptor binding triggers DNA release .
KEGG: vg:1260946
Recombinant P18 (XVIII) protein is a full-length (1-90 amino acids) integral membrane protein from Enterobacteria phage PRD1. The protein has a complete amino acid sequence of MPFGLIVIGIILAIAAYRDTLGELFSIIKDVSKDAKGFGYWVLAAVILGFAASIKPIKEPVNAFMILLMIVLLIRKRGAIDQISNQLRGS. When produced recombinantly, it is typically fused to an N-terminal His-tag and expressed in E. coli expression systems, resulting in a protein with greater than 90% purity as determined by SDS-PAGE . The protein is hydrophobic in nature, containing multiple membrane-spanning regions that integrate into the PRD1 viral membrane during natural assembly processes. Understanding this structural composition is essential for designing experiments involving membrane protein reconstitution and functional studies.
For optimal stability and activity, recombinant P18 (XVIII) protein should be stored at -20°C/-80°C upon receipt, with aliquoting necessary for multiple use to avoid repeated freeze-thaw cycles . The lyophilized protein powder is typically supplied in a Tris/PBS-based buffer containing 6% Trehalose at pH 8.0 . For reconstitution, researchers should:
Briefly centrifuge the vial prior to opening to bring contents to the bottom
Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Add glycerol to 5-50% final concentration (50% is recommended) for long-term storage
It's important to note that repeated freezing and thawing is not recommended as it can compromise protein integrity and functional activity.
The primary expression system documented for producing recombinant P18 protein is E. coli . This prokaryotic system offers several advantages for membrane protein expression:
| Expression System | Advantages | Limitations | Optimization Strategies |
|---|---|---|---|
| E. coli | - High yield - Cost-effective - Rapid growth - Well-established protocols | - Potential improper folding - Lack of post-translational modifications - Inclusion body formation | - Lower induction temperature (16-25°C) - Use of specialized E. coli strains (C41, C43) - Co-expression with chaperones |
| Yeast systems | - Better folding - Some post-translational modifications - Higher yield than mammalian cells | - Different lipid composition - Glycosylation patterns differ | - Optimized codon usage - Controlled expression using inducible promoters |
| Insect cells | - Better folding - Post-translational modifications - Lipid composition closer to higher eukaryotes | - Higher cost - Longer production time | - Optimized signal sequences - Baculovirus optimization |
For functional studies of P18, E. coli expression is typically sufficient as the protein does not require complex post-translational modifications and comes from a bacterial phage environment .
Several analytical methods can be employed to verify the purity and integrity of recombinant P18 protein:
SDS-PAGE Analysis: The standard method for determining protein purity (>90% purity is typically achieved) . For membrane proteins like P18, specialized detergent-containing loading buffers may be necessary.
Western Blotting: Using either anti-His antibodies or specific antibodies against P18, similar to methods described for other PRD1 proteins such as P16 . This method not only confirms identity but can also detect degradation products.
Mass Spectrometry: Provides accurate molecular weight determination and can confirm the amino acid sequence.
Circular Dichroism (CD) Spectroscopy: Useful for assessing secondary structure integrity, particularly important for membrane proteins.
Size Exclusion Chromatography: Can determine if the protein exists as monomers or forms higher-order complexes.
For membrane proteins like P18, it's also important to assess proper folding in membrane-mimetic environments using techniques such as proteoliposome reconstitution followed by functional assays.
P18 (XVIII) is part of the complex machinery of PRD1's membrane structure. While the search results don't specifically detail P18's interactions, we can infer potential research approaches based on studies of related PRD1 membrane proteins:
Co-immunoprecipitation (Co-IP): Using antibodies against P18 to pull down interacting partners, similar to techniques used to study other PRD1 vertex proteins .
Yeast Two-Hybrid (Y2H) or Bacterial Two-Hybrid (B2H) Assays: May be used to screen for potential protein-protein interactions, though these can be challenging with membrane proteins.
Proximity-Based Labeling: Techniques such as BioID or APEX2 fusion proteins can identify nearby proteins in the native viral environment.
Cross-linking Mass Spectrometry (XL-MS): Can capture transient or stable interactions between P18 and other viral components.
Cryo-Electron Microscopy: For structural determination of P18 within the context of the viral particle.
Drawing parallels with other PRD1 membrane proteins, P18 might interact with vertex components similar to how P16 links the spike complex to the viral membrane , or like P20 and P22 which connect the packaging machinery to the viral membrane . Experimental designs should consider the integral membrane nature of P18 and the need for appropriate detergents or lipid environments.
The specific role of P18 (XVIII) is not explicitly detailed in the search results, but comparative analysis with other PRD1 membrane proteins allows for informed hypotheses:
To investigate P18's specific role, researchers could:
Generate P18-deficient mutants through amber mutations or CRISPR-based approaches in bacterial hosts carrying PRD1
Analyze structural integrity of resulting viral particles
Conduct complementation studies with wild-type P18
Perform comparative infection assays and structural analyses
These approaches would help distinguish P18's role from that of other membrane proteins like P16, which has been shown to stabilize the spike complex at vertices .
For functional and structural studies of membrane proteins like P18, several reconstitution methods can be employed:
Detergent Micelles:
Use mild detergents (DDM, LDAO, OG)
Advantages: Simple preparation, good for initial solubilization
Limitations: May not fully recapitulate native membrane environment
Liposome Reconstitution:
Preparation of proteoliposomes with defined lipid composition
Methods: Detergent dialysis, rapid dilution, or direct incorporation
Advantages: More native-like environment
Compatible with functional assays such as permeability studies
Nanodiscs:
Using membrane scaffold proteins (MSPs) to create disc-like bilayers
Advantages: Defined size, access to both sides of membrane, compatibility with various biophysical techniques
Particularly useful for cryo-EM studies
Bicelles:
Mixtures of long-chain and short-chain phospholipids
Advantages: Compatible with NMR studies
For P18 specifically, reconstitution should consider the lipid composition of the PRD1 membrane, which differs from host bacterial membranes. A systematic approach would involve:
Initial solubilization in mild detergents
Testing different lipid compositions for reconstitution
Functional verification through assays relevant to hypothesized P18 functions
Structural characterization in the reconstituted system
Distinguishing between functional and structural roles requires multi-faceted experimental approaches:
By correlating structural features with functional outcomes across these experimental approaches, researchers can delineate whether P18 serves primarily as a structural scaffolding protein or has specific functional roles in processes such as membrane reorganization during infection.
Several biophysical techniques can provide valuable insights into P18's membrane topology and dynamics:
A comprehensive characterization would combine multiple techniques, starting with computational predictions of membrane topology based on the known amino acid sequence (MPFGLIVIGIILAIAAYRDTLGELFSIIKDVSKDAKGFGYWVLAAVILGFAASIKPIKEPVNAFMILLMIVLLIRKRGAIDQISNQLRGS) , followed by experimental validation using the techniques above.
When designing experiments with recombinant P18 protein, several critical controls should be implemented:
Protein Quality Controls:
Negative control: Empty vector-expressed preparations
Positive control: Known functional membrane protein expressed under identical conditions
Thermo-stability assessment: Pre-incubation at various temperatures to establish functional stability range
Expression System Controls:
Comparison of P18 expressed in different systems (if available)
Assessment of post-expression modifications
Reconstitution Controls:
Liposomes/nanodiscs without P18
Reconstitution with denatured P18
Reconstitution with varying P18:lipid ratios
Functional Assay Specificity Controls:
Biological Relevance Controls:
Complementation assays with P18-deficient PRD1 phage
Comparison of in vitro findings with in vivo phenotypes
These controls help distinguish specific P18 effects from artifacts and provide context for interpreting experimental results, especially important given the limited direct information available about P18's specific functions.
Studying membrane dynamics during viral infection using recombinant P18 requires sophisticated experimental designs:
Fluorescently Labeled P18:
Site-specific labeling at non-critical residues
Integration into artificial membrane systems
Real-time tracking during membrane transformation events
Reconstituted Systems for Studying Membrane Transformations:
Creation of PRD1-like vesicles with defined protein composition
Monitoring membrane curvature changes under varying conditions
Assessing P18 redistribution during membrane reorganization
High-Resolution Microscopy Approaches:
Single-molecule tracking of labeled P18
Super-resolution microscopy to visualize P18 clustering
Correlative light and electron microscopy to connect dynamics with ultrastructure
Biomimetic Platforms:
Supported lipid bilayers with incorporated P18
Microfluidic systems that mimic infection conditions
Force measurements to assess membrane mechanical properties
Drawing parallels from studies of the PRD1 infection process, where the internal membrane transforms into a tubular structure that protrudes through a vertex and penetrates the cell envelope for DNA injection , researchers could investigate whether P18 participates in this transformation process, perhaps similarly to how other membrane proteins like P16 interact with vertex structures .
Investigating interactions between P18 and portal vertex proteins requires specialized approaches for membrane-associated complexes:
Genetic Approaches:
Construction of PRD1 mutants with tagged versions of P18 and portal proteins
Complementation studies with modified proteins
Synthetic lethal screens to identify functional relationships
Biochemical Methods:
Chemical cross-linking followed by mass spectrometry
Co-immunoprecipitation with membrane-compatible detergents
Blue native PAGE for identifying native complexes
Structural Biology Techniques:
Cryo-electron tomography of PRD1 particles, focusing on portal regions
Sub-tomogram averaging to enhance resolution
Targeted labeling approaches (gold particles, Fab fragments)
Reconstitution Experiments:
In vitro assembly of portal components with and without P18
Activity assays for portal functions (e.g., DNA packaging) in the presence/absence of P18
The PRD1 portal vertex contains proteins P6, P9, P20, and P22, with P9 serving as the packaging ATPase . P20 and P22 are small integral membrane proteins that link P6 and P9 to the viral particle . Investigators could explore whether P18 interacts with these proteins or contributes to portal function differently from the known membrane connectors P20 and P22.
When faced with contradictions between in vitro and in vivo findings regarding P18 function:
Systematic Reconciliation Approach:
Evaluate methodological differences that might explain discrepancies
Consider protein conformation differences between systems
Assess lipid composition variations that may affect function
Quantitative Analysis Framework:
| Parameter | In Vitro Measurement | In Vivo Observation | Potential Reconciliation Strategy |
|---|---|---|---|
| Binding affinity | Direct measurement with purified components | Inferred from genetic studies | Validate with intermediate complexity systems |
| Functional activity | Isolated system measurements | Phenotypic outcomes | Identify missing cofactors or regulators |
| Structural details | High-resolution but static | Lower resolution but native | Integrate data using computational modeling |
Complementary Techniques:
Develop intermediate complexity systems that bridge the in vitro/in vivo gap
Use cellular fractionation to isolate native complexes containing P18
Apply genetic approaches that mimic in vitro conditions (e.g., simplified genetic backgrounds)
Contextual Factors to Consider:
Stage of viral life cycle being examined
Host cell variations
Presence of other viral proteins that modify P18 function
Insights from studies of other PRD1 membrane proteins suggest that context is critical—for example, P16's role in stabilizing spike complexes was only fully understood through the analysis of P16-deficient virions in the context of intact viral particles .
Computational methods can provide valuable insights for studying P18:
Structural Prediction Methods:
Alpha-helical transmembrane domain prediction tools (TMHMM, HMMTOP)
Ab initio modeling with membrane-specific force fields
Homology modeling using known structures of similar viral membrane proteins
Molecular Dynamics Simulations:
All-atom simulations in explicit membrane environments
Coarse-grained approaches for larger scale dynamics
Steered molecular dynamics to assess membrane deformation properties
Protein-Protein Interaction Prediction:
Docking algorithms optimized for membrane proteins
Sequence coevolution analysis to identify interacting surfaces
Integrative modeling incorporating sparse experimental constraints
Functional Site Prediction:
Conservation analysis across related phages
Identification of physicochemical property patterns associated with specific functions
Machine learning approaches trained on known viral membrane proteins
Simulation-Guided Experimental Design:
Virtual mutagenesis to identify critical residues
Prediction of conformational changes that could be tested experimentally
Identification of potential binding sites for probe attachment
Given P18's sequence (MPFGLIVIGIILAIAAYRDTLGELFSIIKDVSKDAKGFGYWVLAAVILGFAASIKPIKEPVNAFMILLMIVLLIRKRGAIDQISNQLRGS) , computational analysis would likely reveal multiple transmembrane regions and potentially specific motifs that could guide targeted experimental studies of its function in the PRD1 viral membrane.
Several cutting-edge technologies show potential for advancing P18 research:
Cryo-Electron Tomography with Focused Ion Beam Milling:
Enables visualization of P18 in intact virions
Potential to reveal native organization within the membrane
Can capture different states during infection process
Mass Photometry/Interferometric Scattering Microscopy:
Allows label-free detection of protein complexes
Can measure heterogeneity in membrane protein assemblies
Requires minimal sample amounts
Nanobody Development:
Generation of P18-specific nanobodies as research tools
Applications in super-resolution imaging and pull-down assays
Potential to trap specific conformational states
DNA-PAINT Super-Resolution Microscopy:
Can achieve sub-10nm resolution of protein organization
Allows multiplexed imaging of different viral components
Compatible with structural studies of intact virions
Cell-Free Expression Systems:
Rapid prototyping of P18 variants
Direct incorporation into artificial membrane systems
High-throughput functional screening
CRISPR-Based Engineering of Host-Phage Systems:
Precise genome editing of both host and phage
Creation of reporter systems for tracking P18 dynamics
Development of selectable markers for evolutionary studies
These technologies could help resolve outstanding questions about P18's role in the context of PRD1's complex membrane biology and infection mechanisms, particularly in relation to the structural and functional differences between the 11 adsorption vertices and the unique portal vertex .
Comparative evolutionary analyses offer valuable insights:
Phylogenetic Analysis Framework:
Identification of P18 homologs across the Tectiviridae family and related phages
Mapping of conserved domains versus variable regions
Correlation of sequence conservation with known functional elements
Structure-Function Evolutionary Patterns:
Analysis of selective pressure on different protein regions
Identification of co-evolving residues within P18 or between P18 and interacting partners
Assessment of convergent evolution in membrane proteins of unrelated phages
Experimental Approaches:
Functional complementation assays using P18 homologs from related phages
Creation of chimeric proteins to map functional domains
Reconstruction of ancestral P18 sequences to test evolutionary hypotheses
Contextual Evolutionary Considerations:
This evolutionary perspective would complement the structural studies that have revealed similarities between PRD1 and adenovirus, including the double-barrel trimeric capsid proteins and vertex complexes , potentially identifying conserved principles of viral membrane organization across diverse virus families.
Purifying membrane proteins like P18 for structural studies requires specialized approaches:
Optimized Expression Strategies:
Use of specialized E. coli strains (C41/C43, Lemo21)
Controlled induction conditions (lower temperature, reduced inducer concentration)
Addition of specific lipids or chaperones during expression
Extraction and Solubilization:
| Detergent Class | Examples | Advantages | Limitations |
|---|---|---|---|
| Mild non-ionic | DDM, LMNG | Gentle, preserves function | Large micelles |
| Zwitterionic | LDAO, Fos-choline | Effective solubilization | Can be harsher |
| Novel amphipathic agents | SMALPs, amphipols | Maintain native lipid environment | Limited compatibility with some techniques |
Chromatography Sequence:
Quality Control Metrics:
Monodispersity assessment by dynamic light scattering
Thermal stability assays (differential scanning fluorimetry)
Functionality tests in reconstituted systems
Stabilization for Structural Studies:
Screening detergent-lipid combinations
Addition of stabilizing ligands if identified
Nanobody complexation to rigidify flexible regions
For P18 specifically, the purification would start with the reconstitution protocol mentioned in the product information (centrifugation, reconstitution in deionized water) , followed by more specialized steps depending on the intended structural method.
Isotopic labeling of P18 enables advanced structural studies:
Expression Systems for Isotopic Labeling:
Minimal media formulations for E. coli expression
Carbon sources: [13C]-glucose, [13C]-glycerol
Nitrogen sources: [15N]-ammonium chloride
Selective labeling approaches for specific amino acids
Specialized Labeling Strategies:
SAIL (Stereo-Array Isotope Labeling) for improved NMR resolution
Cell-free expression systems for efficient incorporation of non-canonical amino acids
Segmental labeling for focusing on specific regions of P18
Method-Specific Considerations:
For NMR Studies:
Deuteration strategies to reduce spectral complexity
TROSY-based experiments for membrane proteins
Specific labeling patterns optimized for membrane protein studies
For Mass Spectrometry:
SILAC approaches for comparative studies
Hydrogen-deuterium exchange protocols adapted for membrane proteins
Cross-linking MS with isotopically coded cross-linkers
Integration with Other Structural Data:
Combined analysis with cryo-EM data
Integration with computational models
Validation using complementary biophysical techniques
The experimental design should consider P18's membrane protein nature, its relatively small size (90 amino acids) , and the specific research questions being addressed, such as its potential interactions with other PRD1 structural elements or its role in membrane organization.
Research on P18 has broader implications:
Membrane Assembly Models:
Insights into how viral membrane proteins coordinate with host lipids
Understanding selective incorporation mechanisms for specific lipids
Models for membrane curvature induction and maintenance
Membrane Transformation Mechanisms:
Evolutionary Perspectives:
Comparison with other internal membrane-containing viruses
Analysis of convergent solutions to membrane organization challenges
Insights into the origins of viral membrane systems
Methodological Advances:
Development of model systems for studying membrane protein dynamics
Improvement of reconstitution methods for complex membrane assemblies
New approaches for tracking membrane reorganization events
Understanding P18's role could help explain the unique features of PRD1's membrane system, which differs from host bacterial membranes and undergoes dramatic reorganization during infection to form a tube that penetrates the host cell envelope .
Recombinant P18 has potential applications in several areas:
Biotechnology Applications:
Development of novel membrane protein scaffolds
Engineering of protein-based membrane penetration systems
Creation of biomimetic materials inspired by viral membrane organization
Methodological Advances:
Model system for membrane protein reconstitution protocols
Test case for new membrane protein structural determination approaches
Platform for developing membrane protein interaction assays
Therapeutic Development:
Understanding fundamental mechanisms of membrane penetration relevant to drug delivery
Potential inspiration for designing membrane-active peptides
Development of strategies to target bacterial membranes based on phage mechanisms
Synthetic Biology:
Components for engineered virus-like particles
Building blocks for artificial membrane systems with programmable properties
Elements for creating minimal viral systems
These applications leverage the specialized properties of viral membrane proteins like P18, which have evolved to mediate specific membrane-associated functions and structural transitions that could be repurposed for biotechnological and biomedical applications.
Several critical questions remain unanswered:
Structural Organization:
What is the high-resolution structure of P18 in a membrane environment?
How does P18 organize within the PRD1 membrane relative to other membrane proteins?
Does P18 undergo conformational changes during the viral life cycle?
Functional Role:
What specific function does P18 serve in the viral membrane?
How does P18 contribute to membrane stability or reorganization?
Is P18 involved in the membrane tube formation during infection?
Interactions:
Evolutionary Context:
How conserved is P18 across related phages?
Does P18 have functional homologs in other virus families?
What evolutionary pressures have shaped P18's sequence and structure?
Addressing these questions will require integrating multiple experimental approaches, from high-resolution structural studies to functional assays in reconstituted systems and intact virions, building upon the existing knowledge of PRD1 biology and membrane protein biophysics.
Interdisciplinary collaboration offers several advantages:
Integrated Methodological Approaches:
Structural biologists providing high-resolution data on P18 conformation
Biophysicists characterizing dynamic properties and lipid interactions
Virologists establishing functional significance in the viral life cycle
Computational biologists developing integrative models that incorporate diverse data types
Technology Development Synergies:
Creation of specialized tools for membrane protein analysis
Development of viral membrane-mimetic systems
Adaptation of emerging imaging technologies for viral studies
Knowledge Integration Framework:
Systematic data collection across scales (atomic to viral particle)
Standardized protocols for comparing results across laboratories
Shared resources such as antibodies, expression constructs, and mutant collections
Accelerated Research Cycles:
Hypothesis generation from structural studies informing functional experiments
Functional insights guiding targeted structural analyses
Iterative refinement of mechanistic models